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Abstract
Background: Naturally occurring apoptosis is a developmental process that shapes the retina by eliminating
overproduced neurons. In the absence of the proapoptotic Bcl-2 family member BAX, developmental apoptosis in
the retina is disrupted and extra neurons survive. It is unknown how BAX is activated or if this regulation varies
between neuronal types and subtypes. Since the Bcl-2 family members BIM, BID, and BBC3 (PUMA) are powerful
direct activators of BAX, we used mice deficient for each of these genes to investigate their importance in
developmental apoptosis.
Results: Bax deficient mice have an increase in retinal ganglion cells (RGCs), bipolar cells and dopaminergic
amacrine cells, but not photoreceptors, horizontal cells or cholinergic amacrine cells. The retinas of adult Bim and
Bid deficient mice appeared to have no increase in any retinal cell type. Bbc3 deficient mice, either homozygous or
heterozygous for a null allele of Bbc3, had an increase in the same cell types as Bax deficient mice. An analogous
result may occur in the brain where, similar to Bax deficient mice, Bbc3 deficient mice have a larger gross brain
weight compared to wild type mice. In contrast to its developmental role, BBC3 did not appear to be a primary
factor in BAX-dependent axonal injury induced neurodegeneration in adult RGCs.
Conclusion: The regulation of BAX activation in the retina appears to be complex, dependent on the
developmental stage of the animal, the nature of the insult and even the type of neuron.
Introduction
Apoptosis in the retina has a major role in neuronal
development and neurodegeneration. Retinal develop-
ment is a complex process involving the cell fate com-
mitment and differentiation of seven cell types and
numerous cell-subtypes. Cell death is an important
component of determining the final composition of the
retina as most cell types are overproduced during devel-
opment [1,2]. Numerous mechanisms have been sug-
gested to play a role in determining the ultimate
number of retinal neurons [3,4]. For instance, competi-
tion for neurotrophic support was suggested to be
important in determining retinal ganglion cell (RGC)
number. However, even though extensive manipulation
of the neurotrophic deprivation pathway affected the
rate of cell death, it did not alter the final number of
RGCs [4-6]. To date it is unclear what molecular
pathways are critical for determining final cell number
in the retina or other parts of the central nervous sys-
tem (CNS).
It is known that BAX is an important proapoptotic
molecule in retinal development, after RGC axonal
injury, and in glaucoma [1,7,8]. Bax is required in the
developmental cell death of retinal ganglion cells
(RGCs), photoreceptor cells, and at least some retinal
interneurons [1,9]. BAX is a member of the Bcl-2 family
of apoptotic regulators, and BAX activation is a final
step in triggering apoptosis. Numerous other Bcl-2
family members carry out either prosurvival or prodeath
functions by regulating BAX activity. This regulation
carries significance in the retina where BAX overexpres-
sion alone did not alter RGC number [10]. Cell signaling
pathways alter individual Bcl-2 family member activity,
which ultimately determine whether BAX (or BAK1,
another prodeath Bcl-2 family member that is capable
of triggering apoptosis) is activated. During retinal
development, it is unclear what Bcl-2 family members
regulate BAX activation. To understand cell death
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critical steps to activating BAX.
There are at least 7 BH3-only proteins, prodeath
Bcl-2 family members. Three of these, BIM, BBC3
and BID are powerful direct activators of BAX[11].
Doonan and colleagues [12] showed that BIM did not
play a significant role in determining the final number
of retinal neurons, though it might have a minor role
in determining the rate of RGC death during develop-
ment. BID is expressed in the developing retina [13],
but it is not known whether it is activated (truncated)
or has any role in regulating developmental cell
death. BBC3 (also known as PUMA) is expressed in
the developing retina [13]. Interestingly, BBC3 is
known to be critical in some cells after insults that
have been implicated in developmental neuronal
death. For instance, BBC3 is known to play a role in
certain cell types after cytokine withdrawal [14,15]
and following suppression of neuronal activity [16].
Recently, BBC3 has also been shown to be critical for
the death of newly generated neurons in the adult
brain [17,18]. In addition BBC3 is a powerful media-
tor of neuronal apoptosis after various insults in the
adult [19-21].
Here we examine the role of the direct activators of
BAX that have not been assessed, BID and BBC3, to
determine if they are important for BAX activation in
retinal development. There were no obvious changes in
retinal cell number in adult Bid deficient mice. Bbc3
deficiency significantly increases several different retinal
cell types, including RGCs. Interestingly, RGC develop-
mental death and death after axonal injury is BAX
dependent [1,7,8,22], but Bbc3 deficiency only protects
RGCs from developmental death. These data suggest
that BAX dependent apoptotic signaling in RGCs is dif-
ferentially regulated even at the level of BAX activation.
F u r t h e r m o r e ,t h e s ed a t ad e f i n ear o l ef o rB B C 3i nn e u -
ronal development.
Results
Bid deficiency does not alter retinal cell numbers
Neurons in the adult retina reside in three layers of cell
bodies: the ganglion cell layer (GCL), inner nuclear layer
(INL), and outer nuclear layer (ONL), which are con-
nected by two synaptic layers: the inner plexiform layer
(IPL) and the outer plexiform layer (OPL). Developmen-
tal death plays a role in the organization and final num-
ber of neurons in each layer. Both BIM and BID
expression have previously been shown in the develop-
ing retina throughout the time when cell number is
being refined [13]. Bim deficiency delayed developmen-
tal cell death throughout the retina, but did not appear
to affect final cell number [12]. Retinal cross sections of
adult Bim
-/- mice were normal (Figure 1). Similarly, defi-
ciency in Bid did not appear to alter the number of sur-
viving cells in the adult retina (Figure 1). Counts of total
neurons in the ganglion cell layer (GCL; the inner layer
of the retina) of Nissl stained retinal flat mounts con-
firmed that neither BIM nor BID affects cell number in
the GCL (given as % wild type, WT 100 ± 8%; Bid
-/-,
102 ± 4%; Bim
-/-, 106 ± 4%; n = 4 for each genotype, P
> 0.5). In some instances, these BH3-only proteins may
act in consort with other BH3-only proteins [11,23].
Therefore we investigated whether this was true with
BIM and BID. The Bim
-/- Bid
-/- double mutant retinas
had normal morphology (Figure 1) and did not have
extra retinal neurons in the GCL as judged by cell
counts of retinal flat mounts (105 ± 6% of, n = 4; P >
0.5).
Bbc3 deficiency increases neuronal number in the retina
BBC3 expression has been reported during the postnatal
wave of developmental death in the retina [13]; there-
fore, we examined the Bbc3 null retina to see whether
its presence is required for normal retinal development.
Compared to the wild type retina, cross-section thick-
ness progressively increases in Bbc3 heterozygote and
Figure 1 Deficiency in Bim or Bid do not alter adult retinal morphology. Retinal structure for both Bim and Bid deficient animals (aged 6
weeks or more) appeared to be grossly normal with no obvious increase in neuronal number in any retinal layer. Furthermore, no extra cells
were obvious in adult mice that were deficient in both Bim and Bid, Bim
-/- Bid
-/-. At least 3 retinas for each genotype were assessed. ONL, outer
nuclear layer; INL, inner nuclear layer; GCL, ganglion cell layer; scale bar, 50 μm.
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both alleles of Bbc3 (Figure 2A). This increase in size is
due to increased cellularity in the INL and GCL and a
thicker IPL (the synaptic layer between the GCL and
INL) in the Bbc3 mutant retinas. In contrast, the ONL,
which contains photoreceptor cell bodies, appears unaf-
fected. The architecture of the Bbc3 null retina is con-
sistent with the phenotype observed in the Bax null
retina and a disruption of developmental apoptosis (Fig-
ure 2A). However, the phenotype in the Bbc3 heterozy-
gote was unexpected, as there does not appear to be an
increase in retinal neurons in Bax heterozygote mice.
In order to assess the extent of protection in the GCL,
where Bax is known to be important in mediating devel-
opmental cell death [1,7], a modified Nissl stain was
performed on retinal flatmounts (Figure 2B). The total
number of GCL neurons was significantly increased in
the Bbc3
+/- and Bbc3
-/- mice (Figure 2C, P < 0.01).
Quantification of the Bax
+/- retinas yielded no signifi-
cant difference, while in Bax
-/- retinas GCL neurons
were significantly increased (Figure 2C; P < 0.01). These
results are consistent with the retinal cross-sections and
also indicate no significant difference between the Bbc3
and Bax knockouts in terms of the number of GCL
neurons.
BAX contributes to final neuronal number due to its
role in postnatal death [1,24]. To confirm that BBC3
plays a similar role in postnatal cell death, dying cells
were counted in postnatal day 4 retinas, a time when
cells are dying in both the GCL and the developing
outer retina (NBL, which consists of neuronal precur-
sors and differentiated neuronal cells) [2,24]. CASP3
activation (cleaved caspase) was significantly reduced in
both layers of Bbc3
-/- retinas compared to wild type
(Figure 3; P < 0.001). Thus, BBC3 plays a critical role in
the apoptotic death of retinal neurons in the postnatal
retina. It is important to note that there were still occa-
sional dying cells in both layers, suggesting another cas-
pase-dependent cell death pathway eliminates a small
number of retinal cells in the absence of BBC3.
Inner retinal cell types that require BAX for
developmental apoptosis share a BBC3-dependent cell
death pathway
The different types of retinal neurons are overproduced
and eliminated in different amounts [25]. However,
whether similar or different, the cell signaling pathways
responsible for developmental death have not been iden-
tified in any retinal cell type. We sought to determine if
differences between the Bax null and Bbc3 null pheno-
type could identify key cell-type specific differences in
the regulation of apoptotic proteins by assessing
whether all types or a subset of retinal neurons are
affected in each mutant. We quantified which cell types
increased as a result of Bbc3 or Bax deficiency in the
GCL and INL. The ganglion cell layer contains two
types of neurons, RGCs and displaced amacrine cells.
POU4F1 is a specific marker for RGCs and is expressed
in 80% of adult RGCs [26]. Bbc3
+/- and Bbc3
-/- mice had
Figure 2 Deficiency in Bbc3 increases neuron number in the
adult retina.( A) Histological analysis of the retinas of Bbc3
-/- and
Bbc3
+/- mice (aged 6 weeks or more) reveal an increase in thickness
of inner nuclear layer (INL), suggesting an increase in INL neurons.
Similarly, there appears to be an increase in ganglion cell layer
(GCL) neurons. The retinas of Bax
-/- mice also appeared to have an
increase in INL and GCL cells. However, no obvious increase in cell
number was preset in Bax heterozygous mice. No increase in the
number of photoreceptors, which make up the outer nuclear layer
(ONL) was observed in either Bbc3 or Bax deficient retinas. (B) To
confirm the observation of an increase in GCL neurons in Bbc3 and
Bax deficient retinas, GCL neurons were stained in flat mount using
a modified Nissl stain. (C) Cell counts confirmed an increase in GCL
neurons in Bbc3
-/-, Bbc3
+/-, and Bax
-/- neurons. At least 5 retinas
were counted per genotype. Note, for cell counts, endothelial cells
were excluded based on their elongated morphology. *, P < 0.05;
scale bar, 100 μmi nA ,5 0μmi nC .
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and Table 1). The increase was similar to that seen in
Bax
+/- and Bax
-/- mice. Both Bbc3
-/- and Bax
-/- had
approximately twice the number of POU4F1+ cells. In
addition, the percent of RGCs in the GCL in the mutant
mice does not appreciably differ from controls (e.g., %
DAPI+ GCL cells, Bbc3
+/+ 36%; Bbc3
-/- 41%). This result
indicates that the naturally occurring cell death of dis-
placed amacrine cells is also disrupted in the Bbc3
mutants. However, all displaced amacrine cells do not
appear to undergo BBC3 or BAX-dependent cell death.
Deficiency in either Bbc3 or Bax did not effect the final
number of cholinergic displaced amacrine cells (CHAT
+; Figure 4 andTable 1), which make up approximately
20% of displaced amacrine cells in the GCL in wild type
mice [27].
There are three broad types of retinal neuron in the
inner nuclear layer: amacrine cells, bipolar cells, and
horizontal cells. As in the GCL, developmental cell
death of cholinergic (CHAT+) amacrine cells in the INL
did not appear to require BBC3 or BAX (Figure 5 and-
Table 1). However, the number of dopaminergic (TH+)
amacrine cells was increased in Bbc3
-/- and Bax
-/- reti-
nas by over three fold. Interestingly, there was a signifi-
cant increase in dopaminergic amacrine cells in Bbc3
+/-
but not Bax
+/- mice. Similarly, there was a significant
increase in bipolar cells (VSX2+) in Bbc3
+/-, Bbc3
-/- and
Bax
-/- but not Bax
+/- mice. Horizontal cells (CALB1+)
are not known to undergo significant amount of Bcl-2
family dependent death during development [25]. As
expected horizontal cell numbers were similar in retinas
of all genotypes. Overall, these results confirm the vary-
ing amounts to which different types of retinal neurons
are overproduced and eliminated. Despite these differ-
ences BBC3 appears to be the primary activator of BAX
in the developing retina, with the complete loss of BBC3
or BAX resulting in similar phenotypes.
BBC3 contributes to developmental apoptosis in other
regions of the CNS
Developmental apoptosis is an essential component in
the proper development of the entire CNS [22]. Similar
to the retina, a large amount of this naturally occurring
cell death coincides with synapse formation [28]. The
importance of BAX-dependent cell death pathways in
the developing brain has been observed regionally and
by increased gross brain weight in Bax
-/- mice compared
to wild type mice and varies with sex [29]. Similarly, in
Bbc3
-/- mice there was approximately a 15% increase in
gross brain weight compared to wild type mice in both
males and females (Table 2; P < 0.005 for each sex).
Bbc3 deficiency does not prevent RGC death after axonal
insult
Bbc3 appears to be as critical as Bax in the developmen-
tal death of RGCs. Since Bax is required for RGC death
in glaucoma [8] and after optic nerve injury (Figure 6
and [7]), Bbc3’s role in the death of adult RGCs from
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Figure 3 BBC3 is important for cell death in postnatal retinal
neurons.( A) At postnatal day 4, Bbc3
-/- retinas have far fewer
cleaved CASP3+ (dying) cells compared to wild type retinas (arrows
indicate examples of activated CASP3+ cells). (B) The number of
CASP3+ cells was significantly different in both the retinal ganglion
cell layer and the developing outer retina (P = 0.001; n = 3 for each
genotype). Scale bar, 100 μm.
Figure 4 Bbc3 increases the number of ganglion cell layer
neurons in the adult retina. There is an increase in POU4F1 retinal
ganglion cells (red) in both Bbc3 and Bax deficient retinas. The
number of cholinergic amacrine cells (green) is not increased in
either Bbc3 of Bax deficient retinas. Note, CHAT+ cell numbers
where similar to controls in both the inner nuclear layer (INL) and in
the GCL (displaced amacrine cells). Quantification of CHAT and
POU4F1 positive cells are given in table 1. Scale bar, 50 μm.
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showed that significant loss of RGCs occurred in Bbc3
-/-
mice at 7 and 14 days after CONC compared to the
mice undergoing a sham procedure (Figure 6). This
result differs from Bax
-/- mice, where no significant loss
of RGCs was reported 14 days [7] and 21 days [8] after
CONC. In order to assess whether the extent of RGC
loss is diminished following axonal injury in Bbc3
-/-
mice, RGC layer neurons were counted 60 days post
CONC, which is well after the normal period of cell
death. 60 days after axonal injury, wild type retinas lost
44% of RGC layer neurons (Figure 6). Note, approxi-
mately 55% of RGC layer neurons are displaced ama-
crine cells [27] and only RGCs die after direct axonal
injury [30], so the observed loss of 44% of RGC layer
neurons equals complete RGC loss. Bax deficiency con-
tinued to provide complete protection at 60 days, but
the percentage of RGC loss that occurred with Bbc3
deficiency was similar to wild type (Figure 6). Unlike
BAX, BBC3 only has a role in developmental death and
is not a factor in long-term RGC survival after an acute
axonal injury.
Table 1 Specific Cell Counts
Bbc3 Bax
+/+ +/- -/- +/- -/-
POU4F1 100 ± 5.31 136.5 ± 2.3 192.5 ± 4.8 131 ± 3.5 203.4 ± 3.5
GCL-CHAT 100 ± 2.33 93.0 ± 5.2 113.2 ± 12.8 105.8 ± 6.6 96.5 ± 7.5
GCL-DAPI 100 ± 7.8 120.9 ± 3.9 164.2 ± 4.8 112.2 ± 9 190 ± 2.7
INL-CHAT 100 ± 1.0 82.5 ± 5.4 99 ± 7.4 101.7 ± 7.4 91.4 ± 4
TH 100 ± 5.8 194.4 ± 4.4 337.1 ± 3.3 90.3 ± 1.8 380.8 ± 7.28
VSX2 100 ± 6.0 121.7 ± 4.5 146.7 ± 3.6 98 ± 1.9 147.1 ± 3
CALB1 100 ± 3.8 97.7 ± 5. 99.6 ± 1.8 93.9 ± 2.9 92.1 ± 0.7
GCL, ganglion cell layer; INL, inner nuclear layer; n, 3-5 for each genotype and cell type; Bold, P < 0.05
Figure 5 BBC3 is important for the death of several retinal interneurons. Bbc3 and Bax deficiency increased the number of bipolar cells
(VSX2+ cells) but not the number of horizontal cells (CALB1+ cells) in the inner nuclear layer (INL). The number of dopaminergic amacrine cells
(TH), which reside in the INL were assessed in flat mount since there are so few in the retina. Deficiency in either Bbc3 or Bax greatly increased
the number of these cells surviving in the adult retina. Quantification of VSX2, CALB1 and TH positive cells are given in table 1. Scale bar, 50 μm.
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way to determine if there is long-term protection, but
the method may not be sensitive enough to detect a
delay in RGC death. To determine if Bbc3 deficiency
delayed RGC death, the number of CASP3+ cells in
Bbc3
-/- and control retinas were counted at 3 (just as
RGCs begin to die) and 5 days after CONC. At 3 days
after CONC, the first day that significant numbers of
dying RGCs are observed, there were approximately an
equal number of CASP3+ cells in Bbc3
+/+ and Bbc3
-/-
retinas (Bbc3
+/+ 100 ± 8.1; Bbc3
-/- 89.1 ± 13.5; P = 0.5;
N = 9 for each genotype). Given that there are more
RGCs in Bbc3
-/- r e t i n a si ti sp o s s i b l et h a tB B C 3h a sa
small role in RGC death after CONC; a caveat is that
the nerve is bigger which may provide some cushion
from the mechanical trauma of the injury. By 5 days
there were significantly more in the Bbc3
-/- retinas
compared to control, but this increase appears to be in
proportion to the increase in the RGCs in these retinas
(given as percent control ± SEM; Bbc3
+/+100 ± 7.6;
Bbc3
-/- 140.5 ± 12.3; P = 0.023; N = 5 for each geno-
type). Thus, BBC3 does not appear to have a major
role in RGC death after axonal injury.
Discussion
In the central nervous system Bcl-2 family members are
involved in developmental cell death as well as in most
cell death that is the result of trauma and disease [31].
BAX is a powerful prodeath member of the Bcl-2 family.
In fact BAX activation is often a critical step in trigger-
ing apoptosis. BAX activation is tightly controlled by the
interaction of other Bcl-2 family members. Prosurvival
family members antagonize BAX activation while BH3
only proteins, another type of Bcl-2 family prodeath
proteins, facilitate BAX activation [32]. In the retina,
BAX has been reported to be critical for the develop-
mental cell death of many retinal cell types [1,9].
Furthermore, BAX activation is an important step for
the death of adult retina neurons after an insult, includ-
ing for axonally injured RGCs [7,8]. Currently, the com-
plete set of Bcl-2 prosurvival and prodeath proteins that
control BAX activation in developing retinal cells or in
axonally injured RGCs is unknown.
Most retinal neurons are overproduced during devel-
opment and BAX is involved in the programmed cell
death that prunes the extra neurons [22]. The gross
morphology of Bax
-/- retinas has been described [1,24].
In Bax
-/- mice there are approximately twice as many
RGCs compared to wild type retinas [1,22]. Also, the
inner nuclear layer of Bax
-/- r e t i n a si sm u c ht h i c k e r
than controls suggesting that there are more retinal
interneurons (bipolar, amacrine and/or horizontal cells).
We confirmed the involvement of BAX in RGC death.
Furthermore, cell counts showed that BAX is required
for the death of bipolar cells but not horizontal, which
may not be overproduced in large numbers [2,25]. Inter-
estingly, subtypes of amacrine cells differed in their
requirement for BAX. BAX appears to be required for
the death of dopaminergic but not cholinergic cells even
though cholinergic cells are overproduced and die dur-
ing postnatal development [25]. Overexpression of Bcl-
2, a powerful prosurvival member of the Bcl-2 family
that can antagonize all of the prodeath BH3-only pro-
teins results in a similar phenotype as Bax deficiency [25]
with the exception that Bcl2 overexpression produced
Table 2 BBC3 is important for developmental cell death
in the brain
Brain weight (mg) Body weight (g)
Males Bbc3
+/+ 448 ± 5 20.7 ± 0.5
Bbc3
-/- 512 ± 16* 18.8 ± 0.4
Females Bbc3
+/+ 433 ± 15 17.0 ± 0.8
Bbc3
-/- 497 ± 11* 17.0 ± 0.9
All mice used were between 52 and 64 days old. *, P < 0.005 compared to
Bbc3
+/+ of same sex and the effect remains after adjusting for body weight (P
< 0.001). N>5 for each sex and genotype.
Figure 6 BBC3 is not required for the death of adult retinal ganglion cells (RGCs) after axonal injury. Nissl stained flat mounts of
ganglion cell layer (GCL) neurons (left) in Bbc3 deficient mice shows that RGCs are still lost at 7, 14 or 60 days after CONC. Note, only RGCs die
after CONC. Approximately 55% of RGC layer neurons are amacrine cells [27], so a loss of 45% of RGC layer neurons equals complete RGC loss. In
contrast to Bbc3 deficiency, Bax deficiency completely protects RGCs from apoptosis after CONC even out to 60 days. N > 5 for each genotype
and time point.
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ciency. Thus, the Bcl-2 family appears to be important
in developmental cell death of numerous retinal cell
types and the importance of specific family members
can vary even amongst the subtypes of a specific
neuron.
BAX activation likely requires BH3-only proteins.
Mice lacking the BH3-only protein BIM had delayed cell
death in all retinal layers during development [12].
However, adult retinas in Bim
-/- mice appeared to have
normal numbers of retinal cells [12] (and see Figure 1).
Doonan et al., [12] hypothesize that other BH3-only
proteins ultimately are recruited to kill developing ret-
inal neurons. This study left unresolved whether in the
normal retina a BIM-dependent pathway was responsi-
ble for killing developing retinal neurons. To determine
if other BH3-only proteins had a role in retinal develop-
mental death we focused on BID and BBC3, which like
BIM antagonize all the prosurvival family members [33]
and are capable of directly activating BAX, BID and
BBC3 [11]. Bid deficiency did not affect the final num-
ber of retinal neurons. Surprisingly, since it has not
been implicated in neuronal developmental cell death,
BBC3 was required for death in all of retinal cell types
that have BAX dependent developmental death. It
appears that BAX activation during development is
entirely BBC3 dependent. Thus, regulation of BBC3
appears to be a dominant factor determining a cell’s
commitment to die in the developing retina and the
brain.
It is possible that the levels of prosurvival Bcl-2 family
members relative to BBC3 (and other prodeath Bcl-2
family members) are key to determining which neurons
survive naturally occurring developmental cell death in
the postnatal retina. In fact, this model has been sug-
gested to be important in RGC death after axon
injury [34]. In developing retinal neurons BCL2 appears
to be ubiquitously expressed [35]. BCL2 is required for
the survival of a subset of RGCs after the naturally
occurring window of developmental death [36], support-
ing the idea that neuronal survival is normally achieved
by tipping the balance in favor of the prosurvival family
members. However, the absence of BCL2 does not
increase RGC death during the major wave of develop-
mental cell death [36]. This result may be due to a high
level of other prosurvival Bcl-2 family members in
RGCs. BCL2L1 (BCL-XL) is expressed in the developing
central nervous system and is required for survival of
immature neurons [37,38]. Assessing the function of
BCL2L1 and other prosurvival family members in the
developing retina would critically test this possibility. In
addition, it is notable that despite the threshold set by
prosurvival family members and the presence and
importance of BIM (retinal developmental death is
delayed in its absence [12]), BBC3 is specifically required
for death to occur. Therefore, further study of the regu-
lation and/or specificity of BBC3 is needed to under-
stand the processes governing naturally occurring cell
death in the retina.
It is unclear how BBC3 expression is regulated in the
developing retina. The effect that Bbc3 heterozygosity
has in increasing neuronal number indicates that its
transcriptional control is important. Bbc3 expression is
known to be rapidly induced in response to various
insults, including neurotrophic deprivation, by multiple
transcription factors [39]. The death of newly generated
neurons in the adult brain is similar to the death of
developing retinal neurons in that it requires
BBC3 [18,21]. However, Bbc3 expression in the newly
generated adult neurons is dependent on a major regu-
lator of Bbc3 expression, TRP53 [18]. Surprisingly,
TRP53 is not the major regulator of Bbc3 expression
because retinal cell death in development appears to be
Trp53 independent [40]. Bbc3 expression is also known
to be regulated by other transcription factors, including,
TRP73, E2Fs, FOXO3A, JUN and MYC [39]. Knockout
of many of these transcription factors E2fs, Foxo3a
(unpublished data), and Jun (unpublished data) has no
lasting effect on retinal development, at least in terms of
the gross number of retinal neurons. These observations
limit the number of known Bbc3 regulatory pathways
that could be important in determining adult neuronal
number.
Many physiological processes influence cell death in
the developing retina and are potentially upstream of
BBC3, including neurotrophin signaling, electrical activ-
ity, and refinement of spatial patterning [3,4,41]. How-
ever, manipulations of these processes differ from Bbc3
deficiency in that they only affect the rate of cell death
and do not alter adult neuronal number (e.g. [3-6]).
Interestingly, electrical activity has been suggested to be
important in maintaining RGC survival in develop-
ment [42] and synaptic activity can suppress Bbc3
expression, in a Trp53 independent manner, in develop-
ing neurons [16]. Though, it is unclear how electrical
activity regulates Bbc3 activity, perhaps understanding
this link may lead to the identification of molecules
important in determining neuronal number in the CNS.
Bax deficiency also prevents apoptosis after axonal
injury from a mechanical trauma [7,8] or ocular hyper-
tension (glaucoma) [8]. Unlike during developmental
apoptosis, Bbc3 deficiency did not change the time
course of RGC death after axonal injury. This is perhaps
not surprising since Bim deficiency [43] completely
inhibited cell death in the RGC layer for 4 days after
axotomy in explant culture. It is unclear if BAX activa-
tion in RGCs is completely dependent on BIM because
longer time points were not examined. In hippocampal
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response to the same insult [17,44]. It will be interesting
to determine if Bim deficiency provides long-term pro-
tection to RGCs after axonal injury. If it does not, it is
possible that BBC3 ultimately is capable of killing RGCs
after axonal injury.
Conclusion
BBC3-dependent BAX activation is required for devel-
opmental cell death of many retinal cell types. Since
BBC3 appears to be critical for the developmental cell
death of a number of different types of neurons, under-
standing how it is regulated will help to identify the
molecular mechanisms that control neuronal number in
the mammalian CNS. Unlike in developmental apopto-
sis, axonal injury-induced death of RGCs, BAX activa-
tion did not require BBC3. Thus, in vivo and in an
insult-dependent manner, different BH3-only proteins
control BAX activation even in the same neuronal cell
type.
Methods
Animals
Null alleles of Bbc3
tm1Gpz [45] (a generous gift from
Gerard Zambetti), Bim
tm1.1Ast (the Jackson Laboratory
stock number 004524) and Bid
tm1Sjk [46], were sepa-
rately backcrossed at least 10 times into C57BL/6J prior
to our receiving them. All colonies were maintained by
intercrossing. Mice were maintained in a 12-hour light
dark cycle and were fed chow and water ad libitum. All
experiments were conducted in accordance with the
Association for Research in Vision and Ophthalmology’s
statement on the use of animals in ophthalmic research
and were approved by the University of Rochester’s Uni-
versity Committee on Animal Resources.
Tissue Collection, Plastic Sections and Flat mounts
Plastic sections were obtained as previously
described [8,47]. Briefly, eyes were fixed by immersion
in 2.5% gluteraldehyde and 2% paraformaldehyde at 4°C
for 24 hours. Then eyes were dehydrated and embedded
in technovit, 2.5 μm sections were cut, and sections that
included the optic nerve were stained with cresyl violet.
Retinal flat mounts were performed as previously
described [8,47]. For RGC layer counts 2 40× fields
from each retinal quadrant approximately 1 40× field
from the margin of the retina were used for each retina.
All cells within the field were counted except endothe-
lial cells, which have an obvious elongated, non-neuro-
nal morphology. For the total count for each retina, all
eight fields were added together. To determine brain
weights mice were weighed, anesthetized, and transcar-
dially perfused with 4% paraformaldehyde. The entire
brain was then removed and weighed.
Immunohistochemistry and Cell Counts
Eyes were fixed in 4% paraformaldehyde in PBS at room
temperature. The anterior segment was removed and
the resultant eye cup was either processed for cryosec-
tioning or whole mount staining. For immunohisto-
chemistry on retinal sections, cryosections were blocked
by incubating in 10% horse serum in 0.3% Triton X-100
in PBS, pH 7.3, for one hour at room temperature. Pri-
mary antibodies diluted in 0.1% Triton X-100 in PBS
(PBST) containing 5% horse serum were then applied
o v e r n i g h ta t4 ° C .T h ef o l l o w ing day the sections were
washed and treated for two hours with Alexafluor-con-
jugated secondary antibodies (Invitrogen) diluted in
PBST. Each section was also counterstained with DAPI.
GCL neuronal nuclei (DAPI), retinal ganglion cells
(anti-POU4F1, Santa-Cruz, 1:200), cholinergic amacrine
cells (anti-CHAT; Millipore, 1:200), and bipolar cells
(anti-VSX2 (CHX10), Exalpha Biologicals, 1:200) were
counted in sections. Only central sections located at or
within 500 um near the optic nerve head (ONH) were
used for counting. Within a section, each marker was
counted in a 440 μm length of retina on each side of
the ONH. This method was repeated on four sections
per retina. For an individual retina the score was the
average of the eight counts. Due to the fewer number of
horizontal cells in the retina, calbindin D (CALB1,
Sigma Aldrich, 1:1000) positive cells were counted over
entire sections. Counts were performed at equivalent
retinal eccentricities near the optic nerve head on four
sections per retina. Dying cells (activated caspase 3 posi-
tive; R&D Systems, 1:500) in the developing retina on
postnatal day 4 were also counted over the entire retinal
section, similarly to the adult horizontal cell counts.
Dopaminergic amacrine cells (anti-TH, Millipore, 1:500)
and activated caspase 3 positive cells in adult retinas
were counted in retinal flat mounts, since there are so
few of these cells in the retina. For flat mounts, retinas
were dissected free of the eye cup and blocked in PBST
+10% horse serum for 4 hours. Retinas were incubated
in primary antibodies diluted in PBST+5% horse serum
for three overnights at 4°C. Counts were performed on
two 20× fields from each quadrant approximately 220
μm from the peripheral edge of the retina (one half of a
20× field). Adult retinas were all between 6 weeks and
12 weeks of age. Four or more adult retinas of each gen-
otype were quantified.
Optic nerve injury
Controlled optic nerve crush (CONC) was performed on
a d u l tm i c ea sp r e v i o u s l yd e s c r i b e d[ 8 ] .T h eo p t i cn e r v e
was crushed approximately 3-6 mm behind the eye for 5
seconds using self closing forceps (Roboz RS-5027).
Retinas were harvested at various time points after the
procedure. RGC layer counts after CONC were
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Page 8 of 10performed on nissl stained retinas as described above.
Unmanipulated contralateral eyes or contralateral eyes
that had a sham surgery performed (no crush of the
optic nerve) were used as control eyes.
Statistical Analysis
At least 3 animals were assessed for each genotype for
all experimental conditions. For cell experiments invol-
ving quantification of results the experimenter was
blinded to genotype and/or experimental group.
ANOVA was used to compare between all genotypes.
Upon finding statistical significant, multiple comparison
tests were performed using the Tukey-Kramer method.
P < 0.05 was considered significant.
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